This information was published on 2025-07-18T00:07:35 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2522766 |
| (220) |
17 Feb 2025
|
| (500) |
Provisions of paragraph 44(3)(b) and/or Reg 4.15A(3)(b) applied.
|
| (511) (510) |
Class 5
Pharmaceutical and medicinal preparations and substances; vaccines |
| (540) | FLUPEMI |
| (550) | Word |
| (730) |
GlaxoSmithKline Biologicals SA
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.